October 2016 Issue of Renal And Urology News
October 2016 Issue of Renal & Urology News
Nephrology Cover Articles
Study reveals 6-fold higher risk of SHPT in patients on furosemide vs hydrochlorothiazide.
Mortality risk is similar whether starting treatment with 1 or 2 sessions per week or with the conventional 3 sessions per week.
Urology Cover Articles
Study identifies 3 biomarkers that could detect increasing risk of worsening AKI in patients with acute cardiorenal syndrome.
Men with 1 or 2 copies of the HSD3B1 (1245C) allele are more likely to experience disease progression.
This approach is associated with a 26% decreased risk of disease recurrence at 15 years compared with alternating therapy with mitomycin C.
Medicine is making progress to refine patient care.
News in Brief
Serum phosphorus and serum creatinine found to be independent predictors of secondary hyperparathyroidism.
Over a median follow-up of 3.7 years, researchers observed 159 incident cases of atrial fibrillation.
In a study of 189 adult UTI patients who underwent CT scans, investigators identified bacteremia in 40.2%.
Vitamin D supplementation increased the risk of hypercalcemia and hypercalciuria but did not increase the risk of kidney stones.
Patients in the lowest serum sodium group had a 49% increased risk of dying compared with those who had the highest serum sodium levels.
High and low body mass index are can cause renal hematoma for patients undergoing extracorporeal shock wave lithotripsy.
Now providers can be sued for HIPAA violations related to breaches of protected health information.
Prospective study reveals a 1-year surgical intervention rate of 13%.
Enalapril plus folic acid treatment was associated with a 56% reduction in the odds of CKD progression compared with enalapril alone.
In a study, CKD was 16% less likely to develop in low adherers to a DASH dietary pattern.
Compared with computed tomography, ultrasonography demonstrated low sensitivity and overestimated the stones 10 mm or less in size.
Study reveals a significantly higher risk of a 50% or greater decline in eGFR and end-stage graft failure.
More than half of newly diagnosed ESRD patients visit the emergency department during their first year of treatment.
Greatest racial disparity found in Los Angeles, the least in Minneapolis.
Higher albuminuria emerges as a significant predictor of hospitalization for GI bleeding.
Even black men with relatively few comorbidities had increased risks of upgrading or upstaging compared with non-black patients.
A recent study resulted in a new definition of less-than-optimal response to erythropoiesis-stimulating agents.
Using the drug together with allopurinol helps more patients achieve target uric acid levels of less than 6 mg/dL.
Hypo- and hyperthyroidism predict an increased risk of all-cause mortality.
Guidelines for kidney recipients differ on frequency of cancer screenings.
Patients' pre-existing urinary problems influenced their perceptions of symptom relief after prostate cancer treatment.
Therapy was associated with a significant improvement in bone mineral density at the lumbar spine and femoral neck.
Paradoxical association could be related to an altered fatty acid pathway.
For each 1 mmol/L increase in serum phosphorus, the odds of left ventricular hypertrophy more than doubled.
The USDA Standard Nutrient Reference Database, for example, listed phosphorus amounts for just 5 of 46 beverages.
The procedure may be particularly efficacious for men with very large prostates.
A workgroup has developed guidelines for the use of hemodialysis treatments for common toxicities
Two new equations could better descriminate between clinical significant and indolent prostate cancer
In a study, extended-hours versus conventional HD was associated with a 33% decreased mortality risk
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)